Takeda’s CEO under pressure & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Advertisement

Innovate Biopharmaceuticals agreed to acquire Monster Digital, an electronic camera and data storage company.

Forest Laboratories and Allergan filed a suit against Sun Pharma for patent infringement in the District of Delaware’s U.S. District Court.

Takeda Pharmaceuticals President and CEO Christophe Weber could face increased scrutiny after the retirement of Chairman Yasuchika Hasegawa.

The FDA approved Salix Pharmaceuticals’ new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.

Medial EarlySign entered into a strategic collaboration with Medicover for a pilot program aimed at identifying individuals with a high colorectal cancer risk.

More articles on gastroenterology:
Drs. Arnold Rosen, Akash Patel & more: 3 GI physicians making news
5 most read GI/endoscopy stories: June 26 — June 30, 2017
GI leader to know: Dr. Mark Marino of Metropolitan Gastroenterology Associates

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.